tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
IO Biotech downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyIO Biotech downgraded to Neutral from Buy at H.C. Wainwright
28d ago
H.C. Wainwright downgrades IO Biotech after FDA recommends another Phase 3 trial
Premium
The Fly
H.C. Wainwright downgrades IO Biotech after FDA recommends another Phase 3 trial
28d ago
FDA Recommends Against IO Biotech’s Cylembio Application
Premium
Company Announcements
FDA Recommends Against IO Biotech’s Cylembio Application
28d ago
Promising Phase 3 Results and Strategic FDA Engagement Bolster Buy Rating for IO Biotech
PremiumRatingsPromising Phase 3 Results and Strategic FDA Engagement Bolster Buy Rating for IO Biotech
3M ago
IO Biotech Reveals Phase 3 Trial Results for Cylembio
Premium
Company Announcements
IO Biotech Reveals Phase 3 Trial Results for Cylembio
3M ago
IO Biotech says statistical significant missed on primary endpoint for Cylembio
Premium
The Fly
IO Biotech says statistical significant missed on primary endpoint for Cylembio
3M ago
IO Biotech Regains Nasdaq Compliance with Stock Price
PremiumCompany AnnouncementsIO Biotech Regains Nasdaq Compliance with Stock Price
5M ago
IO Biotech files to sell 5.62M shares of common stock for holders
Premium
The Fly
IO Biotech files to sell 5.62M shares of common stock for holders
5M ago
IO Biotech Advances Cancer Vaccine Trials in Q1 2025
Premium
Company Announcements
IO Biotech Advances Cancer Vaccine Trials in Q1 2025
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100